img

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Research Report 2024

Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and are used in the treatment of type 2 diabetes.
According to Mr Accuracy reports’s new survey, global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market is projected to reach US$ 10600 million in 2034, increasing from US$ 9040.4 million in 2024, with the CAGR of 2.3% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market research.
Key manufacturers engaged in the Dipeptidyl Peptidase-4 (DPP-4) Inhibitors industry include Eli Lilly, Glaxo Smith Kline, Boehringer, Bristol-Myers Squibb, Pfizer, AstraZeneca, Sanofi and Novo Nordisk, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Eli Lilly
Glaxo Smith Kline
Boehringer
Bristol-Myers Squibb
Pfizer
AstraZeneca
Sanofi
Novo Nordisk
Segment by Type
Sitagliptin
Saxagliptin
Vildagliptin
Linagliptin

Segment by Application


Hospital
Clinic
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Dipeptidyl Peptidase-4 (DPP-4) Inhibitors report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Overview
1.1 Product Overview and Scope of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
1.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Type
1.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value Comparison by Type (2024-2034)
1.2.2 Sitagliptin
1.2.3 Saxagliptin
1.2.4 Vildagliptin
1.2.5 Linagliptin
1.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Application
1.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Estimates and Forecasts
1.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2018-2034
1.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2018-2034
1.4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competition by Manufacturers
2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price by Manufacturers (2018-2023)
2.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Product Type & Application
2.7 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competitive Situation and Trends
2.7.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players Market Share by Revenue
2.7.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Retrospective Market Scenario by Region
3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2018-2034
3.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2018-2023
3.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region: 2024-2034
3.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region: 2018-2034
3.3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region: 2018-2023
3.3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region: 2024-2034
3.4 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.4.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2018-2034)
3.4.3 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.5.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2018-2034)
3.5.3 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.6.1 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2018-2034)
3.6.3 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.7.1 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2018-2034)
3.7.3 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country
3.8.1 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2018-2034)
3.8.3 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2018-2034)
4.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2018-2023)
4.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Type (2024-2034)
4.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2018-2034)
4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2018-2034)
4.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2018-2023)
4.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Type (2024-2034)
4.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2018-2034)
4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Type (2018-2034)
5 Segment by Application
5.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2018-2034)
5.1.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2018-2023)
5.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Application (2024-2034)
5.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2018-2034)
5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2018-2034)
5.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2018-2023)
5.2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Application (2024-2034)
5.2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2018-2034)
5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Eli Lilly
6.1.1 Eli Lilly Corporation Information
6.1.2 Eli Lilly Description and Business Overview
6.1.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
6.1.5 Eli Lilly Recent Developments/Updates
6.2 Glaxo Smith Kline
6.2.1 Glaxo Smith Kline Corporation Information
6.2.2 Glaxo Smith Kline Description and Business Overview
6.2.3 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
6.2.5 Glaxo Smith Kline Recent Developments/Updates
6.3 Boehringer
6.3.1 Boehringer Corporation Information
6.3.2 Boehringer Description and Business Overview
6.3.3 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
6.3.5 Boehringer Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Corporation Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Novo Nordisk
6.8.1 Novo Nordisk Corporation Information
6.8.2 Novo Nordisk Description and Business Overview
6.8.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Portfolio
6.8.5 Novo Nordisk Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Chain Analysis
7.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Mode & Process
7.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales and Marketing
7.4.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Channels
7.4.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors
7.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers
8 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Dynamics
8.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industry Trends
8.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Drivers
8.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Challenges
8.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competitive Situation by Manufacturers in 2024
Table 4. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units) of Key Manufacturers (2018-2023)
Table 5. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Product Type & Application
Table 12. Global Key Manufacturers of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dipeptidyl Peptidase-4 (DPP-4) Inhibitors as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2018-2023) & (Units)
Table 18. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2018-2023)
Table 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2024-2034) & (Units)
Table 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2024-2034)
Table 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2018-2023)
Table 23. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2024-2034)
Table 25. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2018-2023) & (Units)
Table 27. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2024-2034) & (Units)
Table 28. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2018-2023) & (Units)
Table 32. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2024-2034) & (Units)
Table 33. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2018-2023) & (Units)
Table 37. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2024-2034) & (Units)
Table 38. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2018-2023) & (Units)
Table 42. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2024-2034) & (Units)
Table 43. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2018-2023) & (Units)
Table 47. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2024-2034) & (Units)
Table 48. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units) by Type (2018-2023)
Table 51. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units) by Type (2024-2034)
Table 52. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2018-2023)
Table 53. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2024-2034)
Table 54. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2018-2023)
Table 57. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2024-2034)
Table 58. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2018-2023)
Table 59. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2024-2034)
Table 60. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units) by Application (2018-2023)
Table 61. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units) by Application (2024-2034)
Table 62. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2018-2023)
Table 63. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2024-2034)
Table 64. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2018-2023)
Table 67. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2024-2034)
Table 68. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2018-2023)
Table 69. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2024-2034)
Table 70. Eli Lilly Corporation Information
Table 71. Eli Lilly Description and Business Overview
Table 72. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 74. Eli Lilly Recent Developments/Updates
Table 75. Glaxo Smith Kline Corporation Information
Table 76. Glaxo Smith Kline Description and Business Overview
Table 77. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Glaxo Smith Kline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 79. Glaxo Smith Kline Recent Developments/Updates
Table 80. Boehringer Corporation Information
Table 81. Boehringer Description and Business Overview
Table 82. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Boehringer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 84. Boehringer Recent Developments/Updates
Table 85. Bristol-Myers Squibb Corporation Information
Table 86. Bristol-Myers Squibb Description and Business Overview
Table 87. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 94. Pfizer Recent Developments/Updates
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Novo Nordisk Corporation Information
Table 106. Novo Nordisk Description and Business Overview
Table 107. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product
Table 109. Novo Nordisk Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors List
Table 113. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers List
Table 114. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Trends
Table 115. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Drivers
Table 116. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Challenges
Table 117. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
Figure 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Type in 2024 & 2034
Figure 4. Sitagliptin Product Picture
Figure 5. Saxagliptin Product Picture
Figure 6. Vildagliptin Product Picture
Figure 7. Linagliptin Product Picture
Figure 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Application in 2024 & 2034
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size (2018-2034) & (US$ Million)
Figure 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (2018-2034) & (Units)
Figure 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price (USD/Unit) & (2018-2034)
Figure 17. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Report Years Considered
Figure 18. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Manufacturers in 2024
Figure 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers in 2024
Figure 20. The Global 5 and 10 Largest Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players: Market Share by Revenue in 2024
Figure 21. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 22. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 23. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2018-2034)
Figure 24. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2018-2034)
Figure 25. U.S. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2018-2034)
Figure 28. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2018-2034)
Figure 29. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2018-2034)
Figure 36. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Taiwan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Philippines Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2018-2034)
Figure 47. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2018-2034)
Figure 48. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2018-2034)
Figure 53. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. U.A.E Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2018-2034)
Figure 57. Global Revenue Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2018-2034)
Figure 58. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2018-2034)
Figure 60. Global Revenue Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2018-2034)
Figure 61. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/Unit) by Application (2018-2034)
Figure 62. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Value Chain
Figure 63. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed